Dhruv Bansal, MD

Dr. Dhruv Bansal, an expert in immunotherapy and precision oncology at Endeavor Health, delves into the groundbreaking advancements in cancer treatment. He discusses how precision medicine is bridging genomic research and clinical practice. Notably, he explores why some stage 4 lung cancer patients achieve impressive survival rates, the transformative impact of targeted therapies, and the future role of mRNA vaccines in cancer care. Bansal emphasizes the exciting potential of cellular therapies and collaborative projects combining clinical data with AI to enhance treatment outcomes.